OCGN FY 2021 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$58M

Net Income

-$58M

EPS (Diluted)

$-0.30

Cash Flow

Operating Cash Flow

-$48M

Free Cash Flow

-$49M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$106M

Total Liabilities

$10M

Stockholders' Equity

$96M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$43,000	-100.0%
Gross Profit	$0	-$6M	+100.0%
Operating Income	-$58M	-$21M	-172.6%
Net Income	-$58M	-$22M	-167.5%